Aleva Neurotherapeutics
Series BAleva Neurotherapeutics raised €3.3M in a Series B round in Apr 2012. The company is based in Lausanne, Switzerland. Investors in the round: Banexi Ventures. Data as of Nov 2026.
Amount raised
€3.3M
€3,300,000
Native amount
3,300,000 EUR
Stage
Series B
series b
Investors
1
Provenance & confidence
UnverifiedAmount
Reported in EUR — no conversion. €3.3M
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.